Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Venglustat malate by Sanofi for Gaucher Disease Type III: Likelihood of Approval
Venglustat malate is under clinical development by Sanofi and currently in Phase III for Gaucher Disease Type III. According to...
Venglustat malate by Sanofi for Gaucher Disease Type III: Likelihood of Approval
Venglustat malate is under clinical development by Sanofi and currently in Phase III for Gaucher Disease Type III. According to...
Risk adjusted net present value: What is the current valuation of Sanofi's Venglustat malate?
Venglustat malate is a small molecule commercialized by Sanofi, with a leading Phase III program in Fabry Disease. According to...